Cargando…

Lack of vaccination in ventilated patients for SARS-CoV-2 in France

Detalles Bibliográficos
Autores principales:	Joannes-Boyau, Olivier, Dahyot-Fizelier, Claire
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Société française d'anesthésie et de réanimation (Sfar). Published by Elsevier Masson SAS. 2022
Materias:	Letter to the Editor
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8800504/ https://www.ncbi.nlm.nih.gov/pubmed/35124566 http://dx.doi.org/10.1016/j.accpm.2022.101021

Ejemplares similares

Correspondence on “Lack of vaccination in ventilated patients for SARS-CoV-2 in France”
por: Mungmunpuntipantip, Rujittika, et al.
Publicado: (2022)

Preliminary pragmatic lessons from the SARS-CoV-2 pandemic in France
por: Gauss, Tobias, et al.
Publicado: (2020)

Ventilating multiple patients on a single ventilator: Statement from the French Society of Anaesthesia and Intensive Care (SFAR)
por: Futier, Emmanuel, et al.
Publicado: (2020)

The SARS-CoV-2 seroprevalence is the key factor for deconfinement in France
por: Dimeglio, Chloé, et al.
Publicado: (2020)

Esophagitis and SARS-CoV-2 vaccine
por: Sriwijitalai, Won, et al.
Publicado: (2023)

SARS-CoV-2 and the myths about vaccination()
por: Travezaño-Cabrera, Aaron, et al.
Publicado: (2021)

Immunophenotyping of SARS-CoV-2 and vaccine design
por: Cimolai, Nevio
Publicado: (2022)

Esophagitis and SARS-CoV-2 vaccine: Correspondence
por: Sriwijitalai, Won, et al.
Publicado: (2023)

Acute kidney injury in severe SARS-CoV-2 infection: An experience report in Eastern France
por: Louis, Guillaume, et al.
Publicado: (2021)

Lack of Susceptibility to SARS-CoV-2 and MERS-CoV in Poultry
por: Suarez, David L., et al.
Publicado: (2020)

High SARS-CoV-2 seroprevalence in HIV patients originating from sub-Saharan Africa in the Ile-de-France area: Seroprevalence of SARS-CoV-2 in HIV patients
por: ABDI, Basma, et al.
Publicado: (2022)

Commentary: SARS-CoV-2 vaccines and cancer patients
por: Corti, C., et al.
Publicado: (2021)

Impact of SARS-CoV-2 vaccines on the nervous system
por: Scorza, Fulvio Alexandre, et al.
Publicado: (2022)

Graves’ disease following SARS-CoV-2 vaccination
por: Sriphrapradang, Chutintorn, et al.
Publicado: (2021)

Vaccination of susceptible animals against SARS-CoV-2
por: Xiang, Bin, et al.
Publicado: (2022)

CGRP-monoclonal antibodies and SARS-CoV-2 vaccination
por: Schiano di Cola, Francesca, et al.
Publicado: (2022)

SARS‐CoV‐2 vaccinations can trigger polyradiculitis
por: Finsterer, Josef, et al.
Publicado: (2022)

Subacute thyroiditis and different SARS-CoV-2 vaccine
por: Mungmunpuntipantip, Rujittika, et al.
Publicado: (2022)

An FFP2 respirator mandate for healthcare workers to prevent transmission of SARS-CoV-2 lacks proportionality
por: Knobloch, J.K., et al.
Publicado: (2022)

SARS CoV2 mRNA vaccines: Prolonged dosing intervals and anti-SARS-CoV-2 immunity status
por: Ghazvini, Kiarash, et al.
Publicado: (2022)

SARS CoV2 mRNA vaccines: Prolonged dosing intervals and anti-SARS-CoV-2 immunity status
por: Ghazvini, Kiarash, et al.
Publicado: (2022)

Non-epileptic myoclonus status can be due to both SARS-CoV-2 infection and SARS-CoV-2 vaccination
por: Finsterer, Josef
Publicado: (2023)

Screening for SARS-CoV-2 antibodies among healthcare workers in a university hospital in southern France
por: Dimeglio, Chloé, et al.
Publicado: (2021)

SARS-CoV-2 antibody response eight months after vaccination with mRNA vaccines. Influence of prior SARS-CoV-2 exposure
por: García-Cruces-Méndez, Jesús Fernando, et al.
Publicado: (2022)

Negative anti-SARS-CoV-2 S antibody response following Pfizer SARS-CoV-2 vaccination in a patient on ocrelizumab
por: Khayat-Khoei, Mahsa, et al.
Publicado: (2021)

Vitamin D deficiency and inactivated SARS-CoV-2 vaccines
por: Wu, Chia-Chao, et al.
Publicado: (2021)

Deaths associated with newly launched SARS-CoV-2 vaccination
por: Mungmunpuntipamtip, Rujittika, et al.
Publicado: (2021)

Acute interstitial nephritis following SARS-CoV-2 vaccination
por: Wu, Henry H L, et al.
Publicado: (2021)

Glomerular endothelial injury following vaccination for SARS-CoV-2
por: Tanemoto, Masayuki, et al.
Publicado: (2021)

SARS-CoV-2 re-infection, vaccination and neutralizing antibodies
por: Bongiovanni, Marco, et al.
Publicado: (2022)

Screening for SARS-CoV-2 antibodies to save vaccine doses
por: Fenollar, Florence, et al.
Publicado: (2022)

Hashimoto encephalopathy after vaccination against SARS-CoV-2
por: Viscasillas Sancho, M., et al.
Publicado: (2022)

Post-SARS-CoV-2 vaccination thrombosis is frequent and ubiquitous
por: Finsterer, Josef
Publicado: (2022)

Sinopharm Vaccine, SARS-CoV-2 Breakthrough Infections and Hemoglobinopathies
por: Mungmunpuntipantip, Rujittika, et al.
Publicado: (2022)

SARS-CoV-2 vaccination and thrombotic risk in myeloproliferative neoplasms
por: Borsani, Oscar, et al.
Publicado: (2023)

There is an urgent need for safer anti-SARS-CoV-2 vaccines
por: Finsterer, Josef
Publicado: (2022)

Drug induced hepatitis and SARS-CoV-2 vaccination: Correspondence
por: Mungmunpuntipantip, Rujittika, et al.
Publicado: (2022)

Detection of SARS-CoV-2 by Use of the Cepheid Xpert Xpress SARS-CoV-2 and Roche cobas SARS-CoV-2 Assays
por: Moran, Angelica, et al.
Publicado: (2020)

Lack of nosocomial transmission to exposed inpatients and coworkers in an investigation of five SARS-CoV-2–infected healthcare workers
por: Mponponsuo, Kwadwo, et al.
Publicado: (2020)

Detection of a SARS-CoV-2 P.1.1 variant lacking N501Y in a vaccinated health care worker in Italy
por: Angeletti, Silvia, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_du65asa0i3tq66v5m61loifock